A Phase II Trial of Intravenous Ontak to Treat Epithelial Ovarian Cancer FIGO Stage III or stage IV, or Extraovarian Peritoneal Carcinoma, Failing or Ineligible for First-Line Therapy
Section of Hematology and Medical Oncology in the News
Bounce for Life info: (504) 988-8840
e-mail: bounce@tulane.edu